Volume | 1,158,060 |
|
|||||
News | - | ||||||
Day High | 74.99 | Low High |
|||||
Day Low | 74.45 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Hologic Inc | HOLX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
74.64 | 74.45 | 74.99 | 74.51 | 74.78 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
19,715 | 1,158,060 | US$ 74.78 | US$ 86,599,176 | - | 64.02 - 82.45 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:55:28 | 7 | US$ 73.93 | USD |
Hologic Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
17.49B | 234.73M | - | 4.05B | 456M | 1.94 | 38.35 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Hologic News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HOLX Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 72.82 | 75.15 | 72.395 | 74.28 | 1,464,654 | 1.69 | 2.32% |
1 Month | 75.64 | 76.44 | 72.02 | 74.36 | 1,344,304 | -1.13 | -1.49% |
3 Months | 74.63 | 79.75 | 72.02 | 75.81 | 1,512,643 | -0.12 | -0.16% |
6 Months | 69.26 | 79.75 | 67.5921 | 74.25 | 1,666,788 | 5.25 | 7.58% |
1 Year | 79.04 | 82.45 | 64.02 | 73.95 | 1,728,803 | -4.53 | -5.73% |
3 Years | 60.96 | 87.88 | 59.78 | 73.75 | 1,688,872 | 13.55 | 22.23% |
5 Years | 46.62 | 87.88 | 26.49 | 66.08 | 1,895,121 | 27.89 | 59.82% |
Hologic Description
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (64% of total sales, boosted by pandemic), breast health (21% of sales, suppressed by pandemic), surgical (12%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (75%), followed by Europe (16%), Asia (6%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts. |